Methylprednisolone/omeprazoleDuodenal perforation and lack of efficacy : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1971卷 / 1期

关键词：

D O I：

10.1007/s40278-023-45291-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：166 / 166

相关论文

共 50 条

[1] Batroxobin/methylprednisolone/somatostatinDuodenal bulb ulcers, intestinal perforation and lack of efficacy: case report
Reactions Weekly, 2022, 1897 (1) : 89 - 89
[2] Methylprednisolone/pembrolizumabArthritis and lack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 261 - 261
[3] Methylprednisolone/plasmaAnaphylaxis and lack of efficacy: case report
Reactions Weekly, 2020, 1825 (1) : 149 - 149
[4] Methylprednisolone/pembrolizumabPneumonitis and lack of efficacy: case report
Reactions Weekly, 2021, 1862 (1) : 297 - 297
[5] Methylprednisolone/pembrolizumabColitis and lack of efficacy: case report
Reactions Weekly, 2023, 1951 (1) : 214 - 214
[6] Methylprednisolone/rivaroxabanVertigo and lack of efficacy: case report
Reactions Weekly, 2023, 1949 (1) : 286 - 286
[7] Methylprednisolone/voriconazoleHepatotoxicity and lack of efficacy: case report
Reactions Weekly, 2022, 1928 (1) : 239 - 239
[8] Methylprednisolone/rituximabNeutropenia and lack of efficacy: case report
Reactions Weekly, 2023, 1945 (1) : 341 - 341
[9] AntineoplasticsIntestinal perforation, duodenal perforation and lack of efficacy: case report
Reactions Weekly, 2020, 1826 (1) : 52 - 52
[10] Methylprednisolone/tislelizumabDrug eruption and lack of efficacy: case report
Reactions Weekly, 2025, 2049 (1) : 221 - 221

← 1 2 3 4 5 →